Yung H. Chyung
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Yung H. Chyung
Keros Therapeutics, Inc. reported in an 8-K filed October 16, 2024 that Yung H. Chyung was appointed Chief Medical Officer, effective November 1, 2024.
“On October 16, 2024, Keros Therapeutics, Inc. (the "Company") announced that Yung H. Chyung, M.D., has been appointed to serve as the Company's Chief Medical Officer, effective as of November 1, 2024, succeeding Simon Cooper, M.B.B.S, in such role.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Keros Therapeutics, Inc. (KROS)
SEC 8-K
Current2024-11-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Keros Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Jasbir Seehra CEO, Chairman, Board Member
- Jean-Jacques Bienaimé Chairman, Board Member
- Annita Tanini Chief Accounting Officer
- Alpna Seth Board Member
- Anne Prener, M.D., Ph.D. Board Member
- Charles Newton Board Member
- Mary Ann Gray Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.